Gerlach WL - Search Results

1

Preclinical characterization of an anti-tat ribozyme for therapeutic application.

Wang L, Witherington C, King A, Gerlach WL, Carr A, Penny R, Cooper D, Symonds G, Sun LQ. Wang L, et al. Among authors: gerlach wl. Hum Gene Ther. 1998 Jun 10;9(9):1283-91. doi: 10.1089/hum.1998.9.9-1283. Hum Gene Ther. 1998. PMID: 9650613

2

Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients.

Macpherson JL, Boyd MP, Arndt AJ, Todd AV, Fanning GC, Ely JA, Elliott F, Knop A, Raponi M, Murray J, Gerlach W, Sun LQ, Penny R, Symonds GP, Carr A, Cooper DA. Macpherson JL, et al. J Gene Med. 2005 May;7(5):552-64. doi: 10.1002/jgm.705. J Gene Med. 2005. PMID: 15655805 Clinical Trial.

3

Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.

Sun LQ, Pyati J, Smythe J, Wang L, Macpherson J, Gerlach W, Symonds G. Sun LQ, et al. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7272-6. doi: 10.1073/pnas.92.16.7272. Proc Natl Acad Sci U S A. 1995. PMID: 7638180 Free PMC article.

4

Anti-HIV ribozymes.

Sun LQ, Ely JA, Gerlach W, Symonds G. Sun LQ, et al. Mol Biotechnol. 1997 Jun;7(3):241-51. doi: 10.1007/BF02740815. Mol Biotechnol. 1997. PMID: 9219238 Review.

5

A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins.

Cooper D, Penny R, Symonds G, Carr A, Gerlach W, Sun LQ, Ely J. Cooper D, et al. Hum Gene Ther. 1999 May 20;10(8):1401-21. doi: 10.1089/10430349950018067. Hum Gene Ther. 1999. PMID: 10365669 Clinical Trial. No abstract available.

6

Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.

Sun LQ, Wang L, Gerlach WL, Symonds G. Sun LQ, et al. Among authors: gerlach wl. Nucleic Acids Res. 1995 Aug 11;23(15):2909-13. doi: 10.1093/nar/23.15.2909. Nucleic Acids Res. 1995. PMID: 7544887 Free PMC article.

7

The use of ribozyme gene therapy for the inhibition of HIV replication and its pathogenic sequelae.

Rigden JE, Ely JA, Macpherson JL, Gerlach WL, Sun LQ, Symonds GP. Rigden JE, et al. Among authors: gerlach wl. Curr Issues Mol Biol. 2000 Apr;2(2):61-9. Curr Issues Mol Biol. 2000. PMID: 11471565 Free article. Review.

8

A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme.

Amado RG, Mitsuyasu RT, Symonds G, Rosenblatt JD, Zack J, Sun LQ, Miller M, Ely J, Gerlach W. Amado RG, et al. Hum Gene Ther. 1999 Sep 1;10(13):2255-70. doi: 10.1089/10430349950017239. Hum Gene Ther. 1999. PMID: 10498256 Clinical Trial. No abstract available.

9

Suppression of smooth muscle cell proliferation by a c-myc RNA-cleaving deoxyribozyme.

Sun LQ, Cairns MJ, Gerlach WL, Witherington C, Wang L, King A. Sun LQ, et al. Among authors: gerlach wl. J Biol Chem. 1999 Jun 11;274(24):17236-41. doi: 10.1074/jbc.274.24.17236. J Biol Chem. 1999. PMID: 10358082 Free article.

10

Catalytic nucleic acids: from lab to applications.

Sun LQ, Cairns MJ, Saravolac EG, Baker A, Gerlach WL. Sun LQ, et al. Among authors: gerlach wl. Pharmacol Rev. 2000 Sep;52(3):325-47. Pharmacol Rev. 2000. PMID: 10977866 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters